To answer these questions, further in-depth characterization of ZBTB20 in clinical samples, along with in vivo cell/tissue-specific manipulation of ZBTB20, will likely provide an insight into tumorigenesis and cancer progression, thus offering evidence-based guidelines for targeted therapy. The gene discussed is ZBTB20; the disease is cancer.